Emergent BioSolutions (NYSE:EBS) will release its financial results for the third quarter and nine months of 2017 immediately after market close on Thursday, November 2, 2017. The company will also host a conference call at 5:00 pm (Eastern Time) at which time members of management will discuss these results, as well as recent business developments, revenue and net income guidance for full year 2017 and revenue guidance for fourth quarter 2017.

This conference call can be accessed live by telephone or via webcast:

Live Teleconference Information:Dial in number:  (855) 766-6521Conference ID:  29706026

Live Webcast Information:Visit https://edge.media-server.com/m6/p/dvysvtww for the live webcast feed.

A replay of the call can be accessed on Emergent’s website emergentbiosolutions.com under “Investors.”

About Emergent BioSolutionsEmergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally emerging public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at emergentbiosolutions.com. Follow us @emergentbiosolu.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280BurrowsR@ebsi.com

Media Contact:Lynn KiefferVice President, Corporate Communications 240-631-3391KiefferL@ebsi.com

Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Emergent Biosolutions Charts.
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Emergent Biosolutions Charts.